Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity

Clin Lymphoma Myeloma Leuk. 2016 May;16(5):e65-70. doi: 10.1016/j.clml.2016.02.035. Epub 2016 Feb 27.

Authors

Vishwanath Sathyanarayanan¹, Wai Chin Foo², Michelle Fanale¹, Jason Westin³

Affiliations

¹ Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
² Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
³ Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: jwestin@mdanderson.org.

PMID: 27050323
DOI: 10.1016/j.clml.2016.02.035

No abstract available

Keywords: Chemotherapy; Hepatic dysfunction; Hodgkin lymphoma; Liver failure; Review.

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bile Ducts / pathology*
Bilirubin / metabolism
Biopsy
Cholestasis / diagnosis*
Cholestasis / etiology*
Humans
Liver / pathology
Lymphoma / complications*
Lymphoma / diagnosis
Lymphoma / drug therapy
Male
Positron-Emission Tomography
Syndrome
Tomography, X-Ray Computed
Treatment Outcome

Substances

Bilirubin